EOD Primary Tumor

This input is used in derivation

Notes

**Note:** In case of multifocal noninvasive tumors (code 000) and in situ tumors (code 050), code 050.

Default

999

NAACCR Item

NAACCR #772
Code Description SS2018 T
000 Non-invasive papillary carcinoma IS
050 Carcinoma in situ involving (WITHOUT stromal invasion) - Periurethral or prostatic ducts - Prostatic urethra IS
100 Subepithelial connective tissue (lamina propria, submucosa) invaded Localized, NOS L
300 Prostate (prostatic stroma) Prostatic ducts RE
400 Bladder neck Periprostatic fat (beyond prostate capsule) RE
700 Adjacent organ(s), NOS Bladder wall Extraprostatic invasion bladder wall Rectal wall Further contiguous extension D
800 No evidence of primary tumor U
999 Unknown; extension not stated Primary tumor cannot be assessed Not documented in patient record Death Certificate Only U
(1) Fritz AG, Ries LAG (eds). **SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998)**, National Cancer Institute, NIH Pub. No. 98-2313, Bethesda, MD, 1998 (2) Young JL Jr, Roffers SD, Ries LAG, Fritz AG, Hurlbut AA (eds.). **SEER Summary Staging Manual-2000: Codes and Coding Instructions**, National Cancer Institute, NIH Pub. No. 01-4969, Bethesda, MD, 2001. (3) Collaborative Stage Work Group of the American Joint Committee on Cancer. **Collaborative Stage Data Collection System User Documentation and Coding Instructions, version 02.05**. American Joint Committee on Cancer (Chicago, IL) (4) Gress, D.M., Edge, S.B., Gershenwald, J.E., et al. **Principles of Cancer Staging**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017: 3-30 (5) Hansel, D.E., Reuter, V.E., McKiernan, J.M., et al. **Urethra**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017: 767-776